Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension
Gespeichert in:
| Veröffentlicht in: | Cardiovascular research 2024-09, Vol.120 (10), p.e41-e43 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e43 |
|---|---|
| container_issue | 10 |
| container_start_page | e41 |
| container_title | Cardiovascular research |
| container_volume | 120 |
| creator | Webb, David J |
| description | |
| doi_str_mv | 10.1093/cvr/cvae140 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3100273344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvae140</oup_id><sourcerecordid>3100273344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c208t-735b4fc609523a3944d0ede7bc8eaef520ea4bfb90cfe75f2d415f1c62dc79293</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZP3iUnEXQ1n93uUYpfUPCiFy9LNjvZRrbJmuwW-u-NbfXoYZgZ5uFheBE6p-SWkoLf6XVIpYAKcoDGNJcy40zIQzQmhMyyKZ_yETqJ8TOtUubiGI14wRgTjI7R5sO2UEG0QbkbrHCwlXeDbsFqrLStsXU9BAMBnAasGnA97lVooLeuwco11vfgonU-nW5wF_waYvKkYWXjlunSrPQymfBy00HY8t6doiOj2ghn-z5B748Pb_PnbPH69DK_X2SakVmf5VxWwugpKSTjihdC1ARqyCs9AwVGMgJKVKYqiDaQS8NqQaWhespqnRes4BN0tfOmN74GiH2ZHtPQtsqBH2LJKSEs51yIhF7vUB18jAFM2QW7UmFTUlL-ZF2mrMt91om-2IuHagX1H_sbbgIud4Afun9N33-9i9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3100273344</pqid></control><display><type>article</type><title>Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Webb, David J</creator><creatorcontrib>Webb, David J</creatorcontrib><identifier>ISSN: 0008-6363</identifier><identifier>ISSN: 1755-3245</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvae140</identifier><identifier>PMID: 39222421</identifier><language>eng</language><publisher>UK: Oxford University Press</publisher><subject>Angiotensinogen - genetics ; Angiotensinogen - metabolism ; Animals ; Antihypertensive Agents - therapeutic use ; Blood Pressure - drug effects ; Blood Pressure - genetics ; Humans ; Hypertension - drug therapy ; Hypertension - genetics ; Hypertension - metabolism ; Hypertension - physiopathology ; RNA Interference ; RNA, Small Interfering - therapeutic use</subject><ispartof>Cardiovascular research, 2024-09, Vol.120 (10), p.e41-e43</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c208t-735b4fc609523a3944d0ede7bc8eaef520ea4bfb90cfe75f2d415f1c62dc79293</cites><orcidid>0000-0003-0755-1756</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39222421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Webb, David J</creatorcontrib><title>Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><subject>Angiotensinogen - genetics</subject><subject>Angiotensinogen - metabolism</subject><subject>Animals</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - genetics</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - genetics</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering - therapeutic use</subject><issn>0008-6363</issn><issn>1755-3245</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZP3iUnEXQ1n93uUYpfUPCiFy9LNjvZRrbJmuwW-u-NbfXoYZgZ5uFheBE6p-SWkoLf6XVIpYAKcoDGNJcy40zIQzQmhMyyKZ_yETqJ8TOtUubiGI14wRgTjI7R5sO2UEG0QbkbrHCwlXeDbsFqrLStsXU9BAMBnAasGnA97lVooLeuwco11vfgonU-nW5wF_waYvKkYWXjlunSrPQymfBy00HY8t6doiOj2ghn-z5B748Pb_PnbPH69DK_X2SakVmf5VxWwugpKSTjihdC1ARqyCs9AwVGMgJKVKYqiDaQS8NqQaWhespqnRes4BN0tfOmN74GiH2ZHtPQtsqBH2LJKSEs51yIhF7vUB18jAFM2QW7UmFTUlL-ZF2mrMt91om-2IuHagX1H_sbbgIud4Afun9N33-9i9A</recordid><startdate>20240902</startdate><enddate>20240902</enddate><creator>Webb, David J</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0755-1756</orcidid></search><sort><creationdate>20240902</creationdate><title>Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension</title><author>Webb, David J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c208t-735b4fc609523a3944d0ede7bc8eaef520ea4bfb90cfe75f2d415f1c62dc79293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Angiotensinogen - genetics</topic><topic>Angiotensinogen - metabolism</topic><topic>Animals</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - genetics</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - genetics</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Webb, David J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Webb, David J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2024-09-02</date><risdate>2024</risdate><volume>120</volume><issue>10</issue><spage>e41</spage><epage>e43</epage><pages>e41-e43</pages><issn>0008-6363</issn><issn>1755-3245</issn><eissn>1755-3245</eissn><cop>UK</cop><pub>Oxford University Press</pub><pmid>39222421</pmid><doi>10.1093/cvr/cvae140</doi><orcidid>https://orcid.org/0000-0003-0755-1756</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-6363 |
| ispartof | Cardiovascular research, 2024-09, Vol.120 (10), p.e41-e43 |
| issn | 0008-6363 1755-3245 1755-3245 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3100273344 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Angiotensinogen - genetics Angiotensinogen - metabolism Animals Antihypertensive Agents - therapeutic use Blood Pressure - drug effects Blood Pressure - genetics Humans Hypertension - drug therapy Hypertension - genetics Hypertension - metabolism Hypertension - physiopathology RNA Interference RNA, Small Interfering - therapeutic use |
| title | Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A33%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zilebesiran,%20a%20ribonucleic%20acid%20interference%20agent%20targeting%20angiotensinogen,%20proves%20a%20promising%20approach%20in%20hypertension&rft.jtitle=Cardiovascular%20research&rft.au=Webb,%20David%20J&rft.date=2024-09-02&rft.volume=120&rft.issue=10&rft.spage=e41&rft.epage=e43&rft.pages=e41-e43&rft.issn=0008-6363&rft.eissn=1755-3245&rft_id=info:doi/10.1093/cvr/cvae140&rft_dat=%3Cproquest_cross%3E3100273344%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3100273344&rft_id=info:pmid/39222421&rft_oup_id=10.1093/cvr/cvae140&rfr_iscdi=true |